Drugs / BMS-914832
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01211808 | Sep → Oct 2010 | atrial fibrillation | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-914832 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01211808 ↗ |
| Route | Oral | “Tablets, Oral, 30 mg, once, 1 day” NCT01211808 ↗ |